Orbimed Advisors increased stake in Terns Pharmaceuticals, Inc. By Investing.com

© Reuters. Orbimed Advisors increased stake in Terns Pharmaceuticals, Inc.

On the 9th of February, Orbimed Advisors added 475 thousand Terns Pharmaceuticals, Inc. (TERN) shares for $8.1 million at an average price of $17.00 per share.
Shares of Terns Pharmaceuticals, Inc. are down -0.96% since the transaction.

Orbimed Advisors’s holding in Terns Pharmaceuticals, Inc. increased to about 2.3 million shares with the purchase.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Most Related Links :
Business News Governmental News Finance News

Need Your Help Today. Your $1 can change life.

[charitable_donation_form campaign_id=57167]

Source link

Back to top button